Showing results 19 to 23 of 23
< previous
| Issue Date | Title | Author(s) |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 26-May-2020 | Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 | Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 15-Jul-2020 | Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic | Kyrou, I; Karteris, E; Robbins, T; Chatha, K; Drenos, F; Randeva, HS |
| 24-Feb-2022 | Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs | Kerslake, R; Randeva, HS; Jonigk, D; Werlein, C; Robertus, JL; Katopodis, P; Jasker, P; Spandidos, DA; Kyrou, I; Karteris, E |
| 26-Jun-2023 | Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models | Kerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C |
